https://www.selleckchem.com/pe....ptide/angiotensin-ii
Broad aspects of NGS panel design and reporting including inherent technological, biological and economic considerations are covered, following which the utility of NGS based testing in AML and MDS are discussed. In current practice, patient care is now strongly shaped by the results of NGS assessment and is considered a vital piece of the puzzle for clinicians as they manage these complex haematological disorders.The diagnosis of acute myeloid leukaemia and related neoplasms in adults is challenging as this requires